J&J/Merck Bolsters Heartburn Lineup With Maximum Strength Pepcid AC
This article was originally published in The Tan Sheet
Executive Summary
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck
You may also be interested in...
Pfizer Looks To Give J&J/Merck Heartburn With Zantac 150 Switch
Pfizer Consumer Healthcare's Rx-to-OTC switch of Zantac 150 appears to be a belated attempt to counter Johnson & Johnson/Merck's approval of Maximum Strength Pepcid AC last year
Pfizer Looks To Give J&J/Merck Heartburn With Zantac 150 Switch
Pfizer Consumer Healthcare's Rx-to-OTC switch of Zantac 150 appears to be a belated attempt to counter Johnson & Johnson/Merck's approval of Maximum Strength Pepcid AC last year
Pfizer Looks To Give J&J/Merck Heartburn With Zantac 150 Switch
Pfizer Consumer Healthcare's Rx-to-OTC switch of Zantac 150 appears to be a belated attempt to counter Johnson & Johnson/Merck's approval of Maximum Strength Pepcid AC last year
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: